Entity Public Float of Adaptimmune Therapeutics PLC from 30 Jun 2016 to 30 Jun 2024

Taxonomy & unit: dei: USD
Description: The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary: Adaptimmune Therapeutics PLC quarterly Entity Public Float in USD history and change rate from 30 Jun 2016 to 30 Jun 2024.
Adaptimmune Therapeutics PLC Entity Public Float for the quarter ending 30 Jun 2024 was $230,884,394, a 21% increase year-over-year.
Source SEC data: View on sec.gov

Entity Public Float, Quarterly (USD)

Entity Public Float, YoY Quarterly Change (%)

Adaptimmune Therapeutics PLC Quarterly Entity Public Float (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2024	$230,884,394	+$39,600,303	+21%	30 Jun 2024	10-K	24 Mar 2025	2024	FY
Q2 2023	$191,284,091	-$53,004,720	-22%	30 Jun 2023	10-K	06 Mar 2024	2023	FY
Q2 2022	$244,288,811	-$339,607,021	-58%	30 Jun 2022	10-K	06 Mar 2023	2022	FY
Q2 2021	$583,895,832	-$775,891,360	-57%	30 Jun 2021	10-K	14 Mar 2022	2021	FY
Q2 2020	$1,359,787,192	+$1,011,238,425	+290%	30 Jun 2020	10-K	25 Feb 2021	2020	FY
Q2 2019	$348,548,767	-$528,983,818	-60%	28 Jun 2019	10-K	27 Feb 2020	2019	FY
Q2 2018	$877,532,585	+$438,985,941	+100%	30 Jun 2018	10-K	27 Feb 2019	2018	FY
Q2 2017	$438,546,644	+$52,241,518	+14%	30 Jun 2017	10-K	15 Mar 2018	2017	FY
Q2 2016	$386,305,126			30 Jun 2016	10-K	13 Mar 2017	2016	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.